Vasopressor agents without volume expansion as a safe alternative to venovenous bypass during cavaplasty liver transplantation
Authors:
- Youmin WuYWYoumin Wu
- Tanya L. OyosTOTanya L. Oyos
- Rou-Yee ChenhsuRCRou-Yee Chenhsu
- Daniel A. KatzDKDaniel A. Katz
- Johnny E. BrianJBJohnny E. Brian
- Stephen C. RayhillSRStephen C. Rayhill
- 27 December 2003
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 76 (12) , 1724-1728
Abstract
Cavaplasty orthotopic liver transplantation (OLT) offers advantages for hepatectomy and implantation and eliminates the risk of outflow obstruction. However, it does require clamping of the cava. This study describes the use of a vasopressor without fluid expansion or venovenous bypass (VB) for hemodynamic control during the anhepatic phase. The cavaplasty OLT technique was used routinely. A vasopressor was administered if the mean arterial blood pressure (MAP) was less than 60 mm Hg after clamping of the cava. If the MAP did not reach 60 mm Hg after adjusting the dosage of the vasopressor, femoro-axillary VB would be used. VB was also indicated for preexisting cardiac disease or for massive hemorrhage from severe portal hypertension and extensive adhesions. Among all the 121 adult cavaplasty OLTs, 33 were supported with VB and 50 received a vasopressor. The remaining 38 were excluded. However, baseline variables were well matched, except that preexisting cardiac disease was more frequent in the VB group. The median dosage of epinephrine was 0.07 microg/kg/min (range 0.01-0.6). The VB and vasopressor groups were similar in the reduction in mean MAP and the accumulation in arterial lactate upon clamping as well as in the central venous pressure upon unclamping. Postreperfusion hypotension was more frequent in the VB than in the vasopressor group (27.3% vs. 4.0%, P=0.006). There was no primary graft nonfunction or intraoperative right heart failure. One patient in the vasopressor group required postoperative temporary dialysis. Ninety-day patient and graft survival for the VB and vasopressor groups were 97.0% vs. 98.0% and 97.0% vs. 94.0%, respectively. Modest doses of vasopressor without volume expansion or VB can maintain hemodynamic stability during the anhepatic phase of cavaplasty OLT.Keywords
This publication has 21 references indexed in Scilit:
- Preoperative and Intraoperative Predictors of Postoperative Morbidity, Poor Graft Function, and Early Rejection in 190 Patients Undergoing Liver TransplantationArchives of Surgery, 2001
- SUPRAHEPATIC VENACAVAPLASTY (CAVAPLASTY) WITH RETROHEPATIC CAVA EXTENSION IN LIVER TRANSPLANTATION: EXPERIENCE WITH FIRST 115 CASESTransplantation, 2001
- Liver transplantation without venovenous bypass: Morbidity and mortality in patients with greater than 50% reduction in cardiac output after vena cava clampingJournal of Cardiothoracic and Vascular Anesthesia, 2001
- CAVAPLASTY FACILITATES THE CAVAL ANASTOMOSIS IN LIVING-RELATED LIVER TRANSPLANTATION USING RIGHT LOBE AND LEFT LATERAL SEGMENT GRAFTS.Transplantation, 2000
- SPECIFIC VASCULAR COMPLICATIONS OF ORTHOTOPIC LIVER TRANSPLANTATION WITH PRESERVATION OF THE RETROHEPATIC VENA CAVA: REVIEW OF 1361 CASESTransplantation, 1999
- ANALYSIS OF THE COMPLICATIONS OF THE PIGGY-BACK TECHNIQUE IN 1,112 LIVER TRANSPLANTSTransplantation, 1999
- Venovenous Bypass in Adult Orthotopic Liver Transplantation: Routine or Selective Use?Journal of the American College of Surgeons, 1998
- Orthotopic Liver Transplantation with Preservation of the Inferior Vena CavaAnnals of Surgery, 1989
- LIVER TRANSPLANTATION WITHOUT VENOUS BYPASSTransplantation, 1987
- Venous Bypass in Clinical Liver TransplantationAnnals of Surgery, 1984